SPHD vs XBI
Invesco S&P 500 High Dividend Low Volatility ETF vs SPDR S&P Biotech ETF
- • SPHD has the lower expense ratio at 0.30% vs 0.35% for XBI.
- • SPHD pays a higher dividend yield (4.78%).
Side-by-side metrics
| Metric | SPHD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.30% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.78% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $3.42B | $10.92B |
YTD return | 14.50% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.39 | 1.01 |
P/E ratio | 15.91 | — |
Last price | $52.60 | $156.41 |
Inception | — | — |
Issuer | Invesco | State Street |
SPHD top holdings
| PFE | Pfizer Inc | 3.76% |
| VZ | Verizon Communications Inc | 3.05% |
| CCI | Crown Castle Inc | 2.94% |
| MO | Altria Group Inc | 2.92% |
| KHC | The Kraft Heinz Co | 2.87% |
| GIS | General Mills Inc | 2.84% |
| VICI | VICI Properties Inc Ordinary Shares | 2.81% |
| CMCSA | Comcast Corp Class A | 2.43% |
| CVX | Chevron Corp | 2.35% |
| OKE | ONEOK Inc | 2.34% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About SPHD
SPHD (Invesco S&P 500 High Dividend Low Volatility ETF) is High-yield, low-volatility S&P 500 stocks. Managed by Invesco, the fund carries $3.4B in assets under management, an expense ratio of 0.30%, a dividend yield of 4.78%. Its largest holding is Pfizer Inc (PFE), which represents 3.8% of the portfolio. Real Estate is the fund's largest sector exposure at 19.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.